There are many potential benefits achievable through cell cord blood stem because they are used to treat various types of blood diseases and disorders. Medical experts researching constantly how cord blood stem cells can potentially improve various conditions and diseases, including type 1 diabetes
Type 1 diabetes is characterized by the inability of the pancreas to produce insulin. As insulin levels decline, glucose accumulates in hazardous steps, which can potentially cause damage to other organs in the body.
Since the cells cord blood stem can differentiate into a variety of cells, the researchers think they can help "re-educate" the immune system of patients with diabetes. A cell transplant cord blood stem separates encourages the pancreas to start producing insulin, which helps break down glucose, and can improve the chances of rebuilding the immune system successfully.
One of the most successful studies using cord blood to treat diabetes was led by Dr. Yong Zhao of the University of Illinois at Chicago. The research team recruited 15 patients with moderate and severe cases of diabetes 1 therapy underwent cord stem cell type from blood, and the results are optimistic. Twelve weeks after treatment, doctors have lowered the daily dose of insulin required in six patients with moderate diabetes by 38%. Other patients with severe diabetes required 25% fewer daily doses of insulin.
While cells from cord blood stem can help improve the lives of patients with type 1 diabetes, the cord blood is not a guaranteed cure. However, doctors are optimistic that future research and testing may improve the chances of finding new opportunities to improve the lives of patients.